Records containing: Primary Pulmonary Hypertension
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-01-21Efficacy and Safety of Riociguat (MK-4836) in Incipient Pulmonary Vascular Disease as an Indicator for Early Pulmonary Arterial Hypertension Double-blind, Randomized, Multicenter, Multinational, Placebo-controlled Phase IIa Study (ESRA)
-
CLINICAL_TRIALS study record update · 2025-02-13Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2025-01-29A Global, Open-Label Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Inhaled LIQ861 (Treprostinil) in Pulmonary Arterial Hypertension (WHO Group 1) Patients
-
CLINICAL_TRIALS study record update · 2024-12-05Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2024-07-30A Phase 3 Open-label, Multicenter Study to Evaluate the Long-term Safety and Tolerability of Inhaled LIQ861(Treprostinil) in Pulmonary Arterial Hypertension (WHO Group 1) Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-11-20Calcium Channel Blockers in Nitric Oxide Non-responder Pulmonary Arterial Hypertension.
-
CLINICAL_TRIALS study record update · 2018-07-18ClinicalTrials.gov study NCT02859194
-
CLINICAL_TRIALS study record update · 2016-03-21Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder